Get Live Data

If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Shield Thera Share Price
  4. Shield Thera Share News
  5. IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Pin to quick picksShield Thera Share News (STX)

Shield Thera Information

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.475
Bid: 1.45
Ask: 1.50
Change: -0.075 (-4.84%)
Spread: 0.05 (3.448%)
Open: 1.55
High: 1.55
Low: 1.475
Prev. Close: 1.55
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Thu, 12th Oct 2023 11:14

Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next week Friday to pursue other opportunities. The firm's company controller, Paul Spoors, will take on the CFO role on an interim basis. Shield says it has engaged an executive search firm to identify a new CFO.

Current stock price: 6.25 pence, down 6.7% on Thursday

12-month change: down 29%

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
27 Sep 2021 14:17

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Read more
17 Aug 2021 12:00

Shield Therapeutics swings to losses in first half

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year.

Read more
17 Aug 2021 11:23

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

Read more
17 Aug 2021 10:57

Shield Therapeutics shares fall as swings to loss in first half

Shield Therapeutics shares fall as swings to loss in first half

Read more
12 Aug 2021 19:25

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

Read more
12 Aug 2021 12:25

Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Korea.

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
24 Jun 2021 19:56

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Read more
18 Jun 2021 15:39

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

Read more
10 Jun 2021 16:12

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:48

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

Read more
28 May 2021 13:37

Shield Therapeutics appoints industry veteran Greg Madison as CEO

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief executive officer, with effect from 1 June.

Read more
24 May 2021 14:44

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
18 May 2021 19:15

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

Read more
123456789

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.